vs

Side-by-side financial comparison of Core Laboratories Inc. (CLB) and PARK NATIONAL CORP (PRK). Click either name above to swap in a different company.

PARK NATIONAL CORP is the larger business by last-quarter revenue ($168.3M vs $121.8M, roughly 1.4× Core Laboratories Inc.). PARK NATIONAL CORP runs the higher net margin — 25.3% vs 4.2%, a 21.1% gap on every dollar of revenue. On growth, PARK NATIONAL CORP posted the faster year-over-year revenue change (2.2% vs -1.4%). PARK NATIONAL CORP produced more free cash flow last quarter ($191.9M vs $517.0K). Over the past eight quarters, PARK NATIONAL CORP's revenue compounded faster (4.9% CAGR vs -3.4%).

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

National Retail Systems, Inc. (NRS) includes Keystone Freight Corp. & National Retail Transportation, Inc. (NRT). NRS is an asset based 3PL founded in 1952. It is headquartered in Lyndhurst, New Jersey, United States.

CLB vs PRK — Head-to-Head

Bigger by revenue
PRK
PRK
1.4× larger
PRK
$168.3M
$121.8M
CLB
Growing faster (revenue YoY)
PRK
PRK
+3.6% gap
PRK
2.2%
-1.4%
CLB
Higher net margin
PRK
PRK
21.1% more per $
PRK
25.3%
4.2%
CLB
More free cash flow
PRK
PRK
$191.4M more FCF
PRK
$191.9M
$517.0K
CLB
Faster 2-yr revenue CAGR
PRK
PRK
Annualised
PRK
4.9%
-3.4%
CLB

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CLB
CLB
PRK
PRK
Revenue
$121.8M
$168.3M
Net Profit
$5.1M
$42.6M
Gross Margin
Operating Margin
1.5%
Net Margin
4.2%
25.3%
Revenue YoY
-1.4%
2.2%
Net Profit YoY
10.4%
EPS (diluted)
$0.11
$2.62

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLB
CLB
PRK
PRK
Q1 26
$121.8M
Q4 25
$138.3M
$168.3M
Q3 25
$134.5M
$169.5M
Q2 25
$130.2M
$168.7M
Q1 25
$123.6M
$157.9M
Q4 24
$129.2M
$164.7M
Q3 24
$134.4M
$170.3M
Q2 24
$130.6M
$157.7M
Net Profit
CLB
CLB
PRK
PRK
Q1 26
$5.1M
Q4 25
$4.9M
$42.6M
Q3 25
$14.2M
$47.2M
Q2 25
$10.6M
$48.1M
Q1 25
$-154.0K
$42.2M
Q4 24
$7.4M
$38.6M
Q3 24
$11.7M
$38.2M
Q2 24
$9.0M
$39.4M
Gross Margin
CLB
CLB
PRK
PRK
Q1 26
Q4 25
20.8%
Q3 25
22.0%
Q2 25
20.3%
Q1 25
19.5%
Q4 24
17.8%
Q3 24
20.5%
Q2 24
21.2%
Operating Margin
CLB
CLB
PRK
PRK
Q1 26
1.5%
Q4 25
11.5%
Q3 25
15.6%
34.3%
Q2 25
11.7%
35.2%
Q1 25
3.6%
32.4%
Q4 24
11.0%
Q3 24
14.7%
27.4%
Q2 24
12.3%
30.6%
Net Margin
CLB
CLB
PRK
PRK
Q1 26
4.2%
Q4 25
3.6%
25.3%
Q3 25
10.6%
27.8%
Q2 25
8.2%
28.5%
Q1 25
-0.1%
26.7%
Q4 24
5.7%
23.5%
Q3 24
8.7%
22.4%
Q2 24
6.9%
25.0%
EPS (diluted)
CLB
CLB
PRK
PRK
Q1 26
$0.11
Q4 25
$0.11
$2.62
Q3 25
$0.30
$2.92
Q2 25
$0.22
$2.97
Q1 25
$0.00
$2.60
Q4 24
$0.15
$2.38
Q3 24
$0.25
$2.35
Q2 24
$0.19
$2.42

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLB
CLB
PRK
PRK
Cash + ST InvestmentsLiquidity on hand
$22.8M
$233.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$275.1M
$1.4B
Total Assets
$587.7M
$9.8B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLB
CLB
PRK
PRK
Q1 26
$22.8M
Q4 25
$22.7M
$233.5M
Q3 25
$25.6M
$218.9M
Q2 25
$31.2M
$193.1M
Q1 25
$22.1M
$237.6M
Q4 24
$19.2M
$160.6M
Q3 24
$21.5M
$201.7M
Q2 24
$17.7M
$261.5M
Total Debt
CLB
CLB
PRK
PRK
Q1 26
Q4 25
$110.3M
Q3 25
$114.1M
Q2 25
$124.6M
Q1 25
$124.4M
Q4 24
$126.1M
Q3 24
$139.9M
Q2 24
$147.6M
Stockholders' Equity
CLB
CLB
PRK
PRK
Q1 26
$275.1M
Q4 25
$266.0M
$1.4B
Q3 25
$271.3M
$1.3B
Q2 25
$261.3M
$1.3B
Q1 25
$253.4M
$1.3B
Q4 24
$246.6M
$1.2B
Q3 24
$250.7M
$1.2B
Q2 24
$240.3M
$1.2B
Total Assets
CLB
CLB
PRK
PRK
Q1 26
$587.7M
Q4 25
$584.0M
$9.8B
Q3 25
$591.4M
$9.9B
Q2 25
$602.1M
$9.9B
Q1 25
$591.5M
$9.9B
Q4 24
$585.1M
$9.8B
Q3 24
$600.5M
$9.9B
Q2 24
$597.8M
$9.9B
Debt / Equity
CLB
CLB
PRK
PRK
Q1 26
Q4 25
0.41×
Q3 25
0.42×
Q2 25
0.48×
Q1 25
0.49×
Q4 24
0.51×
Q3 24
0.56×
Q2 24
0.61×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLB
CLB
PRK
PRK
Operating Cash FlowLast quarter
$4.0M
$198.3M
Free Cash FlowOCF − Capex
$517.0K
$191.9M
FCF MarginFCF / Revenue
0.4%
114.1%
Capex IntensityCapex / Revenue
3.8%
Cash ConversionOCF / Net Profit
0.77×
4.65×
TTM Free Cash FlowTrailing 4 quarters
$22.5M
$328.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLB
CLB
PRK
PRK
Q1 26
$4.0M
Q4 25
$7.9M
$198.3M
Q3 25
$8.5M
$52.6M
Q2 25
$13.9M
$49.7M
Q1 25
$6.7M
$37.9M
Q4 24
$20.6M
$178.8M
Q3 24
$13.1M
$43.8M
Q2 24
$17.1M
$50.9M
Free Cash Flow
CLB
CLB
PRK
PRK
Q1 26
$517.0K
Q4 25
$5.0M
$191.9M
Q3 25
$6.5M
$51.1M
Q2 25
$10.4M
$48.4M
Q1 25
$3.9M
$36.8M
Q4 24
$17.4M
$169.7M
Q3 24
$10.4M
$41.7M
Q2 24
$14.3M
$49.0M
FCF Margin
CLB
CLB
PRK
PRK
Q1 26
0.4%
Q4 25
3.6%
114.1%
Q3 25
4.8%
30.1%
Q2 25
8.0%
28.7%
Q1 25
3.1%
23.3%
Q4 24
13.4%
103.0%
Q3 24
7.7%
24.5%
Q2 24
10.9%
31.1%
Capex Intensity
CLB
CLB
PRK
PRK
Q1 26
Q4 25
2.1%
3.8%
Q3 25
1.5%
0.9%
Q2 25
2.7%
0.8%
Q1 25
2.3%
0.7%
Q4 24
2.5%
5.6%
Q3 24
2.0%
1.2%
Q2 24
2.2%
1.2%
Cash Conversion
CLB
CLB
PRK
PRK
Q1 26
0.77×
Q4 25
1.61×
4.65×
Q3 25
0.60×
1.11×
Q2 25
1.31×
1.03×
Q1 25
0.90×
Q4 24
2.78×
4.63×
Q3 24
1.12×
1.14×
Q2 24
1.90×
1.29×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons